Previous studies have proven that SNHG17 is highly-expressed and carcinogenic in cancers, including melanoma, gastric cancer, and colorectal cancer (Wu et al., 2020; Gao, Liu & Sun, 2019). This evidence concerns the gene SNHG17 and colorectal cancer.